Pharmafile Logo
Pharmafocus logo
Advanced Search

insitro appoints Stephen Hitchcock and Vijay Pande as scientific advisors

December 9, 2025
insitro, scientific advisor

insitro, an AI therapeutics company, has announced the appointment of Stephen Hitchcock and Vijay Pande as scientific advisors. Hitchcock brings …

Appointment

STADA appoints Ole Wendler Pedersen as Executive VP Legal and General Counsel

December 8, 2025
Executive VP Legal and General Counsel, Stada

German pharmaceutical company STADA has announced the appointment of Ole Wendler Pedersen as its new Executive Vice President Legal and …

Appointment

UCB presents positive results for fenfluramine in CDKL5 deficiency disorder

December 8, 2025
Research and Development Neurology, UCB, epilepsy

UCB has announced positive results from its phase 3 GEMZ study, showing that fenfluramine can significantly reduce the frequency of …

News

Teva announces positive results from trial of AJOVY for migraine

December 5, 2025
Research and Development Neurology, Teva, migraine

Teva has announced positive results from the phase 4 PEARL study of AJOVY (fremanezumab), its treatment for chronic (CM) and …

News

Vetter announces leadership transition as Thomas Otto retires

December 5, 2025
Managing Director, Vetter

Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team. Otto has …

Appointment

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025
Sales and Marketing Oncology, Osteoporosis, Samsung Bioepis

Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …

News

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025
Medicus Pharma, chief financial officer

Medicus Pharma has announced the appointment of Carolyn Bonner as Chief Financial Officer (CFO) in addition to her role as …

Appointment

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025
Sales and Marketing Oncology, Osteoporosis, Sandoz

Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …

News

Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer

December 3, 2025
Faron Pharmaceuticals, chief financial officer

Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as its new Chief Financial Officer (CFO). Dekkers most recently …

Appointment

Medicus Pharma shares updates on basal cell carcinoma trials

December 2, 2025
Research and Development Medicus Pharma, Oncology

Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …

News

Arnold & Porter appoints George Jenkins as partner

December 2, 2025
Arnold & Porter, law, life sciences

Arnold & Porter has announced the appointment of George Jenkins as a partner in the firm’s Corporate & Finance practice. …

Appointment

Safeguarding health and well-being for employees – the value of occupational health services

December 1, 2025
Medical Communications Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels

With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …

Feature

Men’s health – a new report from the Department of Health and Social Care

November 28, 2025
Medical Communications Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health

The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …

Feature

Healing the fracture in the system: the case for universal fraction liaison services access

November 28, 2025
Medical Communications, Research and Development Osteoporosis

By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …

Feature

Five Facts about antimicrobial resistance

November 28, 2025
Medical Communications Antimicrobial resistance (AMR), Five Facts

1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …

Feature

Celltrion’s Remsima IV approved by EC in liquid form

November 27, 2025
Research and Development Celltrion Inc, Immunology

Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …

News

One-carbon Therapeutics starts new cancer therapy trial

November 27, 2025
Research and Development Oncology, One-carbon Therapeutics

Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …

News

Major breakthrough in T-cell receptor therapy manufacturing

November 27, 2025
Manufacturing and Production Terumo BCT, cell therapy

For the first time, researchers at the University of Chicago in the US have successfully completed all three critical steps …

News

Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia

November 27, 2025
Product launch Gilead, HIV/AIDS

Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …

News

InnotiveDx gets £1m grant to advance UTI diagnostics system

November 27, 2025
Research and Development Diagnostics, InnotiveDx, Urology

InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026